Cited by 436Inflammatory Bowel DiseaseGut microbiota and healthMicroscopic Colitis

Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis

Open access
Paramsothy, Sudarshan, Paramsothy, Ramesh, Rubin, David T, Kamm, Michael A., Kaakoush, Nadeem O., Mitchell, Hazel M, Castaño-Rodríguez, Natalia·2017·Journal of Crohn s and Colitis

Abstract

BACKGROUND: Faecal microbiota transplantation [FMT] has been investigated as a potential treatment for inflammatory bowel disease [IBD]. We thus performed a systematic review and meta-analysis assessing the effectiveness and safety of FMT in IBD. METHODS: A systematic review was conducted until January 2017. Studies were excluded if patients had co-infection or data were pooled across disease subtypes (ulcerative colitis [UC], Crohn's disease [CD], pouchitis). Clinical remission was established as the primary outcome. Pooled effect sizes and 95% confidence intervals were obtained using the random effects model. RESULTS: In all, 53 studies were included [41 in UC, 11 in CD, 4 in pouchitis]. Overall, 36% [201/555] of UC, 50.5% [42/83] of CD, and 21.5% [5/23] of pouchitis patients achieved clinical remission. Among cohort studies, the pooled proportion achieving clinical remission was 33% (95% confidence interval [CI] = 23%-43%] for UC and 52% [95% CI = 31%-72%] for CD, both with moderate risk of heterogeneity. For four RCTs in UC, significant benefit in clinical remission (pooled odds ratios [[P-OR] = 2.89, 95% CI = 1.36-6.13, p = 0.006) with moderate heterogeneity [Cochran's Q, p = 0.188; I2 = 37%] was noted. Sub-analyses suggest remission in UC improved with increased number of FMT infusions and lower gastrointestinal tract administration. Most adverse events were transient gastrointestinal complaints. Microbiota analysis was performed in 24 studies, with many identifying increased diversity and a shift in recipient microbiota profile towards the donor post-FMT. CONCLUSIONS: FMT appears effective in UC remission induction, but long-term durability and safety remain unclear. Additional well-designed controlled studies of FMT in IBD are needed, especially in CD and pouchitis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ecco-jcc/jjx063

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Paramsothy et al. systematic review and meta-analysis found that rates of clinical remission in UC, CD, and pouchitis were 36, 50.5, and 21.5%, respectively.

    “The results showed that the rates of clinical remission in UC, CD, and pouchitis were 36, 50.5, and 21.5%, respectively.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observa- tional studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology [MOOSE] group. JAMA 2000;283:2008-12.
  2. Borody T, Leis S, McGrath K, et al. Treatment of chronic constipation and colitis using human probiotic infusions. In: Probiotics, Prebiotics and New Foods Conference; September 2-4, 2001; Rome: Universita Urbaniana.
  3. Brandt L, Aroniadis O, Greenberg A, et al. Safety of fecal microbiota trans- plantation [FMT] in immunocompromised [IC] patients with inflamma- tory bowel disease [IBD]. Am J Gastroenterol 2013;108:S556.
  4. Goyal A, Chu A, Calabro K, et al. Safety and efficacy of fecal microbiota transplant in children with inflammatory bowel disease. J Pediatr Gastro- enterol Nutr 2016;63:S212.
  5. Pai N, Popov J, Lee C. A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis [Pedifetch Trial]. J Pediatr Gastroenterol Nutr 2016;63:S79-80.

Cited by

Sorted by citations

Authors
Paramsothy, S., Paramsothy, R., Rubin, D. T., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., & Castaño-Rodríguez, N.
Affiliations
  • UNSW Sydney (AU)
  • Liverpool Hospital (AU)
  • University of Chicago (US)
  • The University of Melbourne (AU)
Venue
Journal of Crohn s and Colitis
Published
2017-05-09
Volume
11
Issue
10
Pages
1180-1199
ISSN
  • 1873-9946 (ISSN-L)
  • 1876-4479
OpenAlex
W2586374101
Cited by
436
References
71
Citations by year
2026: 21 · 2025: 36 · 2024: 41 · 2023: 39 · 2022: 56 · 2021: 56 · 2020: 77 · 2019: 62 · 2018: 40 · 2017: 7
FWCI
6.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Crohn s and Colitis (publishedVersion)
  • PubMed (publishedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
  • UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
Funders
  • Cancer Institute NSW
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Microscopic Colitis
Keywords
fecal microbiota transplantation, inflammatory bowel disease
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Colitis, Ulcerative, Crohn Disease, Humans, Inflammatory Bowel Diseases, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review